Education
About Us
Working with TipRanks
Follow Us
Rua Life Sciences Plc (GB:RUA)
:RUA
RESEARCH TOOLSreports
RUA Stock Chart & Stats
Day’s Range― - ―
52-Week Range9.89p - 15.70p
Previous CloseN/A
Volume378.53K
Average Volume (3M)108.37K
Market Cap
£7.45M
Enterprise ValueN/A
Total Cash (Recent Filing)£3.93M
Total Debt (Recent Filing)£389.00K
Price to Earnings (P/E)36.0
Beta0.49
Next Earnings
Jul 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding62,060,272
10 Day Avg. Volume73,219
30 Day Avg. Volume108,368
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)0.58
Price to Sales (P/S)0.00
P/FCF Ratio-5.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
RUA Life Sciences News
PremiumCompany Announcements
RUA Life Sciences CFO Increases Stake in Company
PremiumCompany Announcements
RUA Life Sciences Reports Robust Revenue Growth and Strategic Expansion
PremiumCompany Announcements
RUA Life Sciences CEO Increases Stake in Company
PremiumCompany Announcements
RUA Life Sciences CEO Increases Shareholding
PremiumCompany Announcements
RUA Life Sciences Achieves Significant Revenue and Profit Growth in H1 2024
PremiumCompany Announcements
RUA Life Sciences Sees Strong Revenue Growth
PremiumCompany Announcements
RUA Life Sciences Acquires Medical Device Firm Abiss---
Options Prices
Currently, No data available
---
Ownership Overview
1.46% Insiders
―
Mutual Funds
― Other Institutional Investors
98.54% Public Companies and
Individual Investors
RUA FAQ
What was Rua Life Sciences Plc’s price range in the past 12 months?
Rua Life Sciences Plc lowest share price was 9.88p and its highest was 15.70p in the past 12 months.
What is Rua Life Sciences Plc’s market cap?
Rua Life Sciences Plc’s market cap is £7.45M.
When is Rua Life Sciences Plc’s upcoming earnings report date?
Rua Life Sciences Plc’s upcoming earnings report date is Jul 22, 2025 which is in 66 days.
How were Rua Life Sciences Plc’s earnings last quarter?
Rua Life Sciences Plc released its earnings results on Dec 11, 2024. The company reported 0.01p earnings per share for the quarter, beating the consensus estimate of N/A by 0.01p.
Is Rua Life Sciences Plc overvalued?
According to Wall Street analysts Rua Life Sciences Plc’s price is currently Overvalued.
Does Rua Life Sciences Plc pay dividends?
Rua Life Sciences Plc does not currently pay dividends.
What is Rua Life Sciences Plc’s EPS estimate?
Rua Life Sciences Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rua Life Sciences Plc have?
Rua Life Sciences Plc has 62,060,272 shares outstanding.
What happened to Rua Life Sciences Plc’s price movement after its last earnings report?
Rua Life Sciences Plc reported an EPS of 0.01p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.77%.
Which hedge fund is a major shareholder of Rua Life Sciences Plc?
Currently, no hedge funds are holding shares in GB:RUA
---
Company Description
Rua Life Sciences Plc
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.
---
Technical Analysis
---